Table 1.
Overview of time points of measurements.
| Pre-intervention | Intervention (eight weeks) | Post-intervention | 3-months follow-up | 12-months follow-up | |
|---|---|---|---|---|---|
| Demographic information | x | ||||
| Patient journal* | x | x | |||
| Concomitant medications | x | x | x | ||
| Adverse events | x | ||||
| Physical examination/test | x | x | |||
|
|||||
| Neuropsychological tests | |||||
|
x | x | x | x | |
| x | x | ||||
| x | x | ||||
| x | x | ||||
| Questionnaires | |||||
|
x | x | x | x | |
| – IPAQ | x | x |
SUD diagnosis (i.e. primary substance of use), comorbidities and therapeutic hours. SUD, Substance use disorder; V˙O2max, Maximal oxygen uptake; BRIEF-A, Behavior rating inventory of executive function-adult; MoCA, Montreal cognitive assessment; IPAQ, International physical activity questionnaire.